ADCT

3.65

3.11% 0.11

Dopo l'orario di chiusura: 3.72 0.07 +1.92%

Adc Therapeutics Sa (ADCT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

$3.54

Aprire:

$3.56

Volume 24 ore:

818.98K

Relative Volume:

0.70

Capitalizzazione di mercato:

$452.15M

Reddito:

$69.56M

Utile/perdita netta:

$-240.05M

Rapporto P/E:

-1.2373

EPS:

-2.95

Flusso di cassa netto:

$-121.90M

1 W Prestazione:

+3.40%

1M Prestazione:

+10.94%

6M Prestazione:

+35.19%

1 anno Prestazione:

+82.50%

Intervallo 1D:

$3.50

$3.7499

Intervallo di 1 settimana:

$3.38

$3.7499

Portata 52W:

$1.05

$4.80

Adc Therapeutics Sa Stock (ADCT) Company Profile

Nome

Adc Therapeutics Sa

Settore

Healthcare (1116)

Industria

Biotechnology (620)

Telefono

41 21 653 02 00

Indirizzo

BIOPOLE, EPALINGES

Dipendente

263

Cinguettio

Prossima data di guadagno

2025-03-21

Ultimi documenti SEC

ADCT's Discussions on Twitter

Confronta ADCT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ADCT Adc Therapeutics Sa	3.65	438.52M	69.56M	-240.05M	-121.90M	-2.95
VRTX Vertex Pharmaceuticals Inc	484.15	118.84B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	812.27	81.61B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	422.50	53.69B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	822.94	49.49B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	176.00	37.34B	447.02M	-1.18B	-906.14M	-6.1812

Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-08	Iniziato	Stephens	Overweight
2024-05-30	Iniziato	Cantor Fitzgerald	Overweight
2024-03-28	Iniziato	Guggenheim	Buy
2023-08-10	Aggiornamento	JP Morgan	Underweight → Neutral
2023-04-24	Downgrade	BofA Securities	Neutral → Underperform
2022-12-06	Iniziato	CapitalOne	Overweight
2022-11-09	Downgrade	BofA Securities	Buy → Neutral
2022-09-21	Iniziato	JP Morgan	Overweight
2022-09-09	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-11-09	Iniziato	Wolfe Research	Outperform
2021-08-17	Ripresa	Jefferies	Buy
2021-08-09	Iniziato	RBC Capital Mkts	Outperform
2021-06-15	Iniziato	Cantor Fitzgerald	Overweight
2020-12-03	Iniziato	Stifel	Hold
2020-10-29	Iniziato	H.C. Wainwright	Buy
2020-06-09	Iniziato	BofA/Merrill	Buy
2020-06-09	Iniziato	Cowen	Outperform

Mostra tutto

Adc Therapeutics Sa Borsa (ADCT) Ultime notizie

Jan 06, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC ... - Bluefield Daily Telegraph

Jan 06, 2026

Will ADC Therapeutics SA stock outperform international peers2026 world cup usa national team round of 32 top scorers high defensive line tactical prediction guide - ulpravda.ru

Jan 06, 2026

Jan 03, 2026

ADC Therapeutics Announces New Employee Inducement Grant - 富途牛牛

Jan 03, 2026

Jan 01, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SAADCT - PR Newswire

Jan 01, 2026

Dec 30, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Graphic Packaging Holding Company - GlobeNewswire Inc.

Dec 30, 2025

Dec 29, 2025

ADC Therapeutics (ADCT) Upgraded to Buy: Here's Why - Yahoo Finance

Dec 29, 2025

Is ADC Therapeutics SA a good long term investmentOptions Trading Strategies & Free Take Advantage Of Momentum - earlytimes.in

Dec 29, 2025

Dec 27, 2025

Corient Private Wealth LLC Makes New Investment in ADC Therapeutics SA $ADCT - MarketBeat

Dec 27, 2025

Dec 19, 2025

Risk Report: Will ADC Therapeutics SA stock beat EPS estimatesQuarterly Profit Report & Fast Gaining Stock Reports - Улправда

Dec 19, 2025

How geopolitical tensions affect ADC Therapeutics SA stockJuly 2025 Analyst Calls & Fast Entry and Exit Trade Plans - Улправда

Dec 19, 2025

Can ADC Therapeutics SA Common Shares stock sustain margin levelsTrade Risk Assessment & Real-Time Stock Entry Alerts - Улправда

Dec 19, 2025

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines - marketscreener.com

Dec 19, 2025

Is ADC Therapeutics SA stock a contrarian buyJuly 2025 Macro Moves & Fast Gaining Stock Strategy Reports - Улправда

Dec 19, 2025

ADC Therapeutics SA (NYSE:ADCT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 19, 2025

Will ADC Therapeutics SA stock beat EPS estimatesMarket Activity Report & Safe Entry Zone Identification - Улправда

Dec 19, 2025

Is ADC Therapeutics SA Common Shares stock testing key supportJuly 2025 WrapUp & Weekly Stock Breakout Alerts - Улправда

Dec 19, 2025

Dec 18, 2025

Wall Street Recap: Is ADC Therapeutics SA Common Shares stock undervalued historically2025 EndofYear Setup & Weekly High Return Forecasts - Улправда

Dec 18, 2025

How buybacks impact ADC Therapeutics SA stock value2025 Investor Takeaways & Entry and Exit Point Strategies - Улправда

Dec 18, 2025

Is ADC Therapeutics SA Common Shares stock undervalued historically2025 Big Picture & Weekly Momentum Stock Picks - Улправда

Dec 18, 2025

RBC Capital Bullish on ADC Therapeutics S.A. (ADCT) on Lymphoma Treatment Development - Yahoo Finance

Dec 18, 2025

Dec 17, 2025

Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year? - sharewise.com

Dec 17, 2025

Dec 15, 2025

ADC Therapeutics (NYSE:ADCT) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Dec 15, 2025